Updated COVID-19 Booster Guidance

Apr 01, 2022 | COVID News |

COVID-19 Update from the Nurse-Led COVID Vaccine Confidence Project

Following FDA’s regulatory action on March 29, 2022, the Centers for Disease Control and Prevention (CDC) has updated its COVID-19 vaccination guidance to give some individuals the option to receive a second booster dose using an mRNA COVID-19 vaccine.

What you need to know 

  • The Centers for Disease Control and Prevention (CDC) updated its COVID-19 vaccination guidance to give some individuals the option to receive a second booster dose using an mRNA COVID-19 vaccine.
  • Eligible individuals have the option to receive a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccines.
  • Since the risk of severe COVID-19 increases with age, adding second booster dose eligibility for older adults helps to ensure those at highest risk are protected from severe disease.
  • CDC, FDA, and other federal partners continue to monitor and evaluate the data, including whether additional booster doses may be needed for other populations in the future. On April 6, FDA will gather its independent panel of outside experts to discuss considerations for another booster for the broader population. CDC will participate in this public meeting. 

Who is eligible for a COVID-19 vaccine booster? 

The following groups are eligible for a second booster dose:

  • 50 years and older and received an initial COVID-19 booster dose (regardless of which vaccine was used) at least 4 months ago
  • 12 years and older, moderately or severely immunocompromised, and previously received any booster dose at least 4 months ago
  • 18 years and older, and previously received the J&J/Janssen COVID-19 vaccine for both the primary dose and your booster dose, are now able to receive an mRNA COVID-19 booster dose at least 4 months after J&J/Janssen booster dose

Along with the recommendation, the CDC emphasized that vaccination remains the best way to protect yourself, reduce the spread of the virus, and help prevent new variants from emerging. CDC continues to monitor and evaluate evidence and data as it is available to inform guidance, including whether or when additional doses for other populations may be needed.

 

COVID-19 Vaccine Toolkit

This toolkit was designed to help you decrease vaccine hesitancy and increate vaccination rates in your community.
CLICK HERE

 

This project was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000580). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.

 

LATEST NEWS

Updated COVID-19 Booster Guidance for Children

23 May 2022
On May 19, 2022 the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on...

NNCC Receives AmeriCorps Public Health Nursing Program Award

09 May 2022
The National Nurse-Led Care Consortium is proud to announce that it is one of 80 organizations to receive...

 

STAY CONNECTED TO NURSE-LED CARE

  

About The Author

Sierra Little is the Communications Coordinator at the National Nurse-Led Care Consortium.

Subscribe for the
Latest Updates

Subscribe to our email newsletter is the best way to learn about all of NNCC's free webinars and other online learning opportunities.

Subscribe